Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)
Public ClinicalTrials.gov record NCT01374425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MAVERICC (Marker Evaluation for Avastin Research in CRC): A Randomized Phase II Study of Bevacizumab+mFOLFOX6 Vs. Bevacizumab+FOLFIRI With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Cancer
Study identification
- NCT ID
- NCT01374425
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 376 participants
Conditions and interventions
Conditions
Interventions
- 5-Fluorouracil Drug
- Bevacizumab Drug
- Irinotecan Drug
- Leucovorin Drug
- Oxaliplatin Drug
- Capecitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- Apr 30, 2015
- Completion
- Jun 30, 2015
- Last update posted
- Aug 10, 2016
2011 – 2015
United States locations
- U.S. sites
- 65
- U.S. states
- 25
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Little Rock | Arkansas | 72205-7199 | — |
| Not listed | Bellflower | California | 90706 | — |
| Not listed | Duarte | California | 91010 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Hayward | California | 94545 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Oakland | California | 94611 | — |
| Not listed | Pleasant Hill | California | 94523 | — |
| Not listed | Roseville | California | 95661 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | San Jose | California | 95119 | — |
| Not listed | Santa Clara | California | 95051 | — |
| Not listed | South San Francisco | California | 94080 | — |
| Not listed | Vallejo | California | 94589 | — |
| Not listed | Walnut Creek | California | 94596 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Stamford | Connecticut | 06902 | — |
| Not listed | Trumbull | Connecticut | 06611 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Port Saint Lucie | Florida | 34952 | — |
| Not listed | Boise | Idaho | 83712 | — |
| Not listed | Joliet | Illinois | 60435 | — |
| Not listed | Maywood | Illinois | 60153 | — |
| Not listed | Peoria | Illinois | 61615 | — |
| Not listed | Goshen | Indiana | 46526 | — |
| Not listed | Indianapolis | Indiana | 46237 | — |
| Not listed | Terre Haute | Indiana | 47802 | — |
| Not listed | Fairway | Kansas | 66205 | — |
| Not listed | Elizabethtown | Kentucky | 42791 | — |
| Not listed | Scarborough | Maine | 04074 | — |
| Not listed | Burlington | Massachusetts | 01805 | — |
| Not listed | Billings | Montana | 59102 | — |
| Not listed | Lincoln | Nebraska | 68506 | — |
| Not listed | Cherry Hill | New Jersey | 08003 | — |
| Not listed | Manasquan | New Jersey | 08736 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Albuquerque | New Mexico | 87110 | — |
| Not listed | Albuquerque | New Mexico | 87131-5636 | — |
| Not listed | Farmington | New Mexico | 87401 | — |
| Not listed | Las Cruces | New Mexico | 88011 | — |
| Not listed | Santa Fe | New Mexico | 87505 | — |
| Not listed | Rochester | New York | 14642 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Greensboro | North Carolina | 27403 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Washington | North Carolina | 27889 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Columbus | Ohio | 43219 | — |
| Not listed | Toledo | Ohio | 43623 | — |
| Not listed | Oklahoma City | Oklahoma | 73142 | — |
| Not listed | Dunmore | Pennsylvania | 18512 | — |
| Not listed | Media | Pennsylvania | 19063 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Pittsburgh | Pennsylvania | 15212 | — |
| Not listed | Charleston | South Carolina | 29414 | — |
| Not listed | Corpus Christi | Texas | 78404 | — |
| Not listed | Houston | Texas | 77090 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
| Not listed | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01374425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2016 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01374425 live on ClinicalTrials.gov.